125 related articles for article (PubMed ID: 6759226)
1. In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man.
Gray RS; Scarlett JA; Griffin J; Olefsky JM; Kolterman OG
Diabetes; 1982 Oct; 31(10):929-36. PubMed ID: 6759226
[TBL] [Abstract][Full Text] [Related]
2. In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man.
Glauber HS; Revers RR; Henry R; Schmeiser L; Wallace P; Kolterman OG; Cohen RM; Rubenstein AH; Galloway JA; Frank BH
Diabetes; 1986 Mar; 35(3):311-7. PubMed ID: 3512341
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.
Prager R; Wallace P; Olefsky JM
J Clin Invest; 1986 Aug; 78(2):472-81. PubMed ID: 3525609
[TBL] [Abstract][Full Text] [Related]
4. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
5. Insulin action during pregnancy. Studies with the euglycemic clamp technique.
Ryan EA; O'Sullivan MJ; Skyler JS
Diabetes; 1985 Apr; 34(4):380-9. PubMed ID: 3882502
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of insulin resistance in aging.
Fink RI; Kolterman OG; Griffin J; Olefsky JM
J Clin Invest; 1983 Jun; 71(6):1523-35. PubMed ID: 6345584
[TBL] [Abstract][Full Text] [Related]
7. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
8. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
9. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
10. Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles.
Mudaliar S; Mohideen P; Deutsch R; Ciaraldi TP; Armstrong D; Kim B; Sha X; Henry RR
Diabetes Care; 2002 Sep; 25(9):1597-602. PubMed ID: 12196433
[TBL] [Abstract][Full Text] [Related]
11. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph.
Poulin RA; Steil GM; Moore DM; Ader M; Bergman RN
Diabetes; 1994 Feb; 43(2):180-90. PubMed ID: 8288041
[TBL] [Abstract][Full Text] [Related]
13. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
14. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Rebrin K; Steil GM; Mittelman SD; Bergman RN
J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of insulin action in vivo. Identification of rate-limiting steps.
Miles PD; Levisetti M; Reichart D; Khoursheed M; Moossa AR; Olefsky JM
Diabetes; 1995 Aug; 44(8):947-53. PubMed ID: 7622001
[TBL] [Abstract][Full Text] [Related]
16. Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levels.
Meneilly GS; Minaker KL; Elahi D; Rowe JW
J Gerontol; 1987 Mar; 42(2):196-201. PubMed ID: 3546473
[TBL] [Abstract][Full Text] [Related]
17. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
Prager R; Wallace P; Olefsky JM
Diabetes; 1987 May; 36(5):607-11. PubMed ID: 3552793
[TBL] [Abstract][Full Text] [Related]
19. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
20. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
